Livewire Markets on MSN
Is CSL giving you a headache? Here are 6 ASX biotech firms for the watchlist
Two experts share the Aussie names with big catalysts on the horizon.
The Offering was led by healthcare-dedicated investors including Janus Henderson Investors, HBM Healthcare Investments and Samsara ...
The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...
Levee Medical, a medical device innovator focused on improving outcomes for men undergoing prostate cancer surgery, today announced the close of an additional round of ?nancing totaling over $12 ...
Both biotech stocks could be the breakout growth story in 2026. The post These 2 ASX healthcare shares could jump well over 80% appeared first on The Motley Fool Australia.
IDEAYA Biosciences, Inc. , a leading precision medicine oncology company, provided a business update and announced financial results for the fourth quarter and full year ended December 31, ...
PFS events confirmed by BICR in the Phase 2/3 OptimUM-02 trial of darovasertib and crizotinib combination in 1L HLA*A2-negative metastatic uveal melanoma ...
Eckert & Ziegler and the Nuclear Physics Institute of the Czech Academy of Sciences have scaled up production of the critical medical isotope Actinium-225, moving from development into larger-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results